Join Growin Stock Community!
Beta
Back to PFE.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • P/E Ratio
  • P/S Ratio
  • P/B Ratio
  • EV/EBITDA
  • EV/Sales
  • PE Ratio River
pb-ratio-chart

PFE P/B Ratio

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for PFE's P/B Ratio in Q1'26 stands at 1.75, reflecting a modest decline of 1.6% from the previous quarter's value of 1.78 in Q4'25, indicating a slight compression in the stock's valuation relative to its book value. Over the period from Q2'23 to Q1'26, the P/B Ratio has exhibited a predominantly downward trend, starting at 2.04 and reaching a low of 1.50 in Q1'25 before a partial rebound to 1.75, with an overall decline of approximately 14% that suggests increasing market skepticism toward the company's asset valuation amid volatility in the pharmaceutical sector. Notable fluctuations include a temporary uptick to 1.92 in Q2'24, followed by consistent softening through Q3'25, highlighting periods of relative stability interspersed with downward pressure.